| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/11/1994 | WO1994010195A1 Calcium channel blocking polypeptides from heteropoda venatoria |
| 05/11/1994 | WO1994010193A1 Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
| 05/11/1994 | WO1994010187A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b) |
| 05/11/1994 | WO1994010170A1 Substituted quinuclidines as substance p antagonists |
| 05/11/1994 | WO1994010165A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 05/11/1994 | WO1994010164A1 4-quinolinyl derivatives with anti-helicobacter activity |
| 05/11/1994 | WO1994010162A1 Dopamine receptor subtype ligands |
| 05/11/1994 | WO1994010151A1 Substituted phthalazinones as nerotensin antagonists |
| 05/11/1994 | WO1994010148A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis |
| 05/11/1994 | WO1994010145A1 Dopamine receptor subtype ligands |
| 05/11/1994 | WO1994009815A1 USES OF TGF-β RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT |
| 05/11/1994 | WO1994009806A1 Preparation for therapeutic and especially prophylactic treatment of digestive tract disorders |
| 05/11/1994 | EP0596675A1 Artificial saliva compositions |
| 05/11/1994 | EP0596326A1 Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing the same, use thereof and precesses for their production |
| 05/11/1994 | EP0596049A1 Defoaming composition |
| 05/11/1994 | EP0595924A1 Platelet activating factor antagonists |
| 05/11/1994 | CA2148685A1 Truncated insulin-like growth factor binding proteins having mitogenic activity |
| 05/11/1994 | CA2148504A1 Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 05/11/1994 | CA2148255A1 Preparation for therapeutic and especially prophylactic treatment of digestive tract disorders |
| 05/11/1994 | CA2147754A1 Compositions and methods for modifying the regulatory activity of tgf- .beta. |
| 05/11/1994 | CA2147504A1 Substituted phthalazinones as neurotensin antagonists |
| 05/11/1994 | CA2146767A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 05/11/1994 | CA2146651A1 4-quinolinyl derivatives with anti-helicobacter activity |
| 05/11/1994 | CA2146019A1 Dopamine receptor subtype ligands |
| 05/11/1994 | CA2146018A1 Dopamine receptor subtype ligands |
| 05/11/1994 | CA2136076A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis |
| 05/10/1994 | US5310743 1-acylpiperidine compounds |
| 05/10/1994 | CA1329389C Heterocyclic compounds and antiulcer agents |
| 05/04/1994 | EP0595370A2 Process for the preparation of taxane derivatives and intermediates therefor |
| 05/04/1994 | EP0595111A1 Carbazolone derivatives and process for preparing the same |
| 05/04/1994 | EP0594867A1 Agent for increasing somatostatin or for inhibiting decrease of somatostatin |
| 05/04/1994 | EP0594677A1 Antiviral liponucleosides: treatment of hepatitis b |
| 05/04/1994 | EP0594636A1 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 05/04/1994 | EP0515456B1 Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them |
| 05/04/1994 | CN1086129A Novel treatment |
| 05/03/1994 | US5308850 (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 05/03/1994 | US5308836 Pharmaceutical composition of stabilized [Leu13 ]-motilin-Hse |
| 05/03/1994 | US5308833 Method for treating hepatitis B carriers with minimal disease |
| 05/03/1994 | US5308618 Dietary fiber extracted from wheat bran pharmaceutical and dietary compositions containing same |
| 05/03/1994 | CA2108808A1 Man-made saliva fluids |
| 05/03/1994 | CA1329204C Imidazo [4,5-.beta.] pyridine compounds and process for preparing same |
| 05/03/1994 | CA1329203C Esters of hexahydro-8-hydroxy-2, 6-methano-2h- quinolizin-3(4h)-one and related compounds |
| 05/03/1994 | CA1329201C Thioformanidins, their preparation and use as drugs |
| 05/03/1994 | CA1329199C Method of treating cachexia and certain new compounds for use in this method |
| 04/28/1994 | WO1994009023A1 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION |
| 04/28/1994 | WO1994008998A1 Imidazopyridine derivatives as 5-ht4 receptor antagonists |
| 04/28/1994 | WO1994008997A1 Substituted benzylaminoquinuclidines as substance p antagonists |
| 04/28/1994 | WO1994008995A1 Heterocyclic condensed benzoic acid derivatives as 5-ht4 receptor antagonists |
| 04/28/1994 | WO1994008994A1 Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists |
| 04/28/1994 | WO1994008965A1 N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists |
| 04/28/1994 | WO1994008598A1 Liver reserve cells |
| 04/28/1994 | WO1994008588A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
| 04/28/1994 | CA2147352A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives and use thereof |
| 04/28/1994 | CA2146930A1 Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists |
| 04/28/1994 | CA2146928A1 Imidazopyridine derivatives as 5-ht4 receptor antagonists |
| 04/28/1994 | CA2146923A1 Heterocyclic condensed benzoic acid derivatives as 5-ht4 receptor antagonists |
| 04/28/1994 | CA2146862A1 The taga gene and methods for detecting predisposition to peptic ulceration |
| 04/27/1994 | EP0594257A1 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 04/27/1994 | EP0594235A2 Method of purification of amylase, purified amylase so obtained and uses of purified amylase |
| 04/27/1994 | EP0594000A1 Substituted (pyridinylamino)-benzisoxazoles and benzoisothiazole a process for their preparation and their use as medicaments |
| 04/27/1994 | EP0593639A1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same. |
| 04/27/1994 | EP0593463A1 Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
| 04/27/1994 | CN1085903A Pharmaceutical compounds |
| 04/27/1994 | CN1024346C Antihypertensive 3-piperidinyl-indazole derivatives |
| 04/26/1994 | US5306818 Treating degenerative diseases such as emphysema, rheumatoid arthritis and pancreatitis |
| 04/26/1994 | CA1328948C Polypeptide compounds |
| 04/26/1994 | CA1328875C N-substituted amide derivatives |
| 04/24/1994 | CA2105731A1 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 04/22/1994 | CA2108800A1 Substituted (pyridinylamino)-benzisoxazoles and -benzoisothiazoles, a process for their preparation and their use as medicaments |
| 04/20/1994 | EP0593339A1 Process preparation of hepatitis A antigen and vaccine |
| 04/20/1994 | EP0593290A2 Core antigen protein of hepatitis C virus, and diagnostic method and kit using the same |
| 04/20/1994 | EP0592562A1 Bmp-9 compositions |
| 04/20/1994 | EP0592478A1 Use of lipases to produce drugs |
| 04/20/1994 | EP0408711B1 S-adenosyl-methionine in the treatment of pancreatitis and of the immuno rejection in the pancreas transplant |
| 04/20/1994 | CN1085557A Enatiomeric hydroxylated xanthine compounds |
| 04/20/1994 | CN1085427A Novel acrylic acid salts, a process for their preparation, pharmaceutical compositions containing them and their use in the medicine |
| 04/20/1994 | CN1024275C Process for preparing morphologically homogeneous forms of thiazole derivatives |
| 04/19/1994 | CA1328623C2 Antibacterial antiplaque, anticalculus oral composition |
| 04/19/1994 | CA1328619C Toxicity profiles in chemotherapy |
| 04/14/1994 | WO1994007859A1 5-ht4 antagonists |
| 04/14/1994 | WO1994007830A1 A mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
| 04/14/1994 | WO1994007523A1 Antimicrobial peptides |
| 04/14/1994 | WO1994007517A1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 04/14/1994 | WO1994007479A2 Immunopotentiatory agents |
| 04/14/1994 | WO1994007474A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 04/14/1994 | WO1994007473A1 CONTROLLED-pH FORMULATION FOR INTRAVESICULAR INSTILLATION OF TGFαPE40ab |
| 04/14/1994 | WO1994007467A1 Calcium polycarbophil sprinkle |
| 04/14/1994 | WO1994001095A3 Medicaments for the treatment of visceral pain and migraine |
| 04/14/1994 | WO1994000113A3 Medicaments containing 5-ht4 receptor antagonists |
| 04/14/1994 | CA2146572A1 Controlled-ph formulation for intravesicular instillation of tgfpe40 ab |
| 04/14/1994 | CA2145746A1 5-ht4 antagonists |
| 04/13/1994 | EP0591891A2 Benzimidazole derivatives as Angiotensin II antagonists |
| 04/13/1994 | EP0591584A1 N-Alkyl-3-phenyl-3-(2-halo-substituted phenoxy)Propylamines as norepinephrine uptake inhibitors |
| 04/13/1994 | EP0591446A1 Method for treating helicobacter pylori gastritis |
| 04/13/1994 | EP0591426A1 Sigma receptor ligands and the use thereof |
| 04/13/1994 | EP0591395A1 Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron |
| 04/13/1994 | EP0591275A1 Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions |
| 04/12/1994 | US5302718 Compounds containing an amino salicylic acid moiety linked to a sulphapyridine moiety via stable bridge |
| 04/12/1994 | US5302398 Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids |
| 04/12/1994 | US5302396 Superior tasting composition having porous particles and the process of preparing such pharmaceutical composition |